Novo Nordisk is the pharmaceutical firm achieving the greatest levels of engagement across its social media channels, according to a new report.
Ogilvy Healthworld UK has published The Social Media Check-up in conjunction with Pulsar, which reveals that Novo Nordisk recorded high engagement with its social media posts, despite posting at a below-average frequency.
“Novo Nordisk has high levels of engagement across its social media platforms, despite not being one of the pharma sector's most frequent posters.“
Meanwhile, Johnson & Johnson was the pharma firm with the second highest levels of engagement, followed by Merck/MSD in third place, Novartis in fourth and GSK in fifth.
However, Roche, Amgen and Pfizer were the pharmaceutical firms posting on social media the highest number of times, which demonstrates that it is a case of quality over quantity when it comes to securing engagement on these channels.
Speaking to PRWeek, Chloe Partikas, social media director at Ogilvy Healthworld, commented: "It is clear that the pharma social media space is changing. Pharma is reaching social media maturity, posting more strategically and tailoring content to the channel and audiences."
She added that firms need to continue to adapt, however, in order to stay ahead of the game.
With over 20 years of experience within the healthcare communications market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current healthcare communications roles we have available, you can search for the latest job roles, register your details, or contact the team today.
Image credit: dalebor via iStockSee all the latest jobs in Healthcare Communications